He maikaʻi nā hopena no nā mea hoʻomohala hoʻāʻo antigen, ka mea i ʻike i ka hāʻule ʻana o ka noi ma hope o ka hoʻokuʻu ʻia ʻana o ke kano.
Ua ʻike ʻia kahi noiʻi liʻiliʻi e ka National Institutes of Health (NIS) i ka maikaʻi o ka Covid-19 lateral flow test (LFT) e like me ka hoʻāʻo polymerase chain reaction (PCR) i ka ʻike ʻana i ka maʻi SARS-CoV-2.Hana ʻia i kēlā me kēia ʻekolu lā Hoʻokahi kānana.
Ua manaʻo ʻia nā hoʻokolohua PCR i ke kūlana gula no ka hoʻomaʻamaʻa ʻana i ka maʻi Covid-19, akā ua kaupalena ʻia kā lākou hoʻohana ʻana i nā mea hana screening no ka mea pono lākou e hana ʻia i loko o ka hale hana a hiki i nā hopena ke lawe i kekahi mau lā a hiki i nā maʻi.
Ma ka ʻokoʻa, hiki i ka LFT ke hāʻawi i nā hopena i loko o 15 mau minuke, a ʻaʻole pono nā mea hoʻohana e haʻalele i ka home.
Ua hōʻike nā mea noiʻi me ka NIH Diagnostic Rapid Acceleration Program i nā hopena o 43 mau kānaka i loaʻa i ka maʻi Covid-19.No ke Kulanui o Illinois ma Urbana-Champaign (UIUC) ka papahana screening SHIELD Illinois Covid-19.Ua hoʻāʻo maikaʻi lākou iā lākou iho a i pili pū paha me nā poʻe i hōʻike maikaʻi.
Ua ʻae ʻia nā mea komo i loko o kekahi mau lā ma hope o ka ʻike ʻana i ka maʻi maʻi, a ʻaʻole maikaʻi nā hopena hōʻike i loko o 7 mau lā ma mua o ke kau inoa ʻana.
Hāʻawi lākou a pau i nā laʻana kohu a me ʻelua ʻano o ka nasal swabs no 14 mau lā, a laila hana ʻia e PCR, LFT, a me ka moʻomeheu virus ola.
He hana koʻikoʻi ka moʻomeheu Virus a ʻaʻole i hoʻohana ʻia i ka hoʻāʻo Covid-19 maʻamau, akā kōkua e hoʻoholo i ke ʻano o ka maʻi mai ka laʻana.Hiki i kēia ke kōkua i nā mea noiʻi e manaʻo i ka hoʻomaka a me ka lōʻihi o ka contagion Covid-19.
Ua ʻōlelo ʻo Christopher Brooke, Polofesa o Molecular and Cell Biology ma UIUC: "ʻO ka hapa nui o nā hoʻāʻo e ʻike i nā mea genetic e pili ana i ka maʻi maʻi, akā ʻaʻole ia he manaʻo he maʻi ola.ʻO ke ala wale nō e hoʻoholo ai inā he maʻi ola, infectious ka hana ʻana i ka Infectivity hoʻoholo a i ʻole ka moʻomeheu.
A laila, ua hoʻohālikelike ka poʻe noiʻi i ʻekolu mau ala ʻike maʻi maʻi Covid-19-ka ʻike ʻana o PCR i ka saliva, ka ʻike ʻana o PCR o nā laʻana ihu, a me ka wikiwiki o ka Covid-19 antigen detection o nā laʻana ihu.
Hana ʻia nā hopena laʻana kohu e kahi hoʻāʻo PCR ʻae ʻia e pili ana i ka saliva i hoʻomohala ʻia e UIUC, i kapa ʻia ʻo covidSHIELD, hiki ke hana i nā hopena ma hope o 12 mau hola.Hoʻohana ʻia kahi hoʻāʻo PCR ʻokoʻa me ka hāmeʻa Abbott Alinity no ka loaʻa ʻana o nā hopena mai nā swabs ihu.
Hana ʻia ka ʻike antigen wikiwiki me ka Quidel Sofia SARS antigen fluorescence immunoassay, LFT, i ʻae ʻia no ka mālama koke a hiki ke hana i nā hopena ma hope o 15 mau minuke.
A laila, ua helu ka poʻe noiʻi i ka naʻau o kēlā me kēia ala i ka ʻike ʻana iā SARS-CoV-2, a ua ana pū kekahi i ka hele ʻana o ka maʻi ola i loko o ʻelua pule o ka maʻi mua.
Ua ʻike lākou ʻoi aku ka maʻalahi o ka hoʻāʻo PCR ma mua o ka hoʻāʻo ʻana i ka antigen Covid-19 i ka wā e hoʻāʻo ai i ka maʻi ma mua o ka manawa o ka maʻi, akā ua kuhikuhi ʻia he mau lā ka hopena o ka PCR e hoʻihoʻi ʻia i ka mea i hoʻāʻo ʻia.
Ua helu ka poʻe noiʻi i ka ʻike hoʻāʻo e pili ana i ka pinepine o ka hoʻāʻo a ʻike ʻia ʻoi aku ka kiʻekiʻe o ka naʻau o ka ʻike ʻana i ka maʻi ma mua o 98% ke hana ʻia ka hōʻike i kēlā me kēia lā ʻekolu, inā ʻo ia ka hōʻike antigen Covid-19 wikiwiki a i ʻole ka hoʻāʻo PCR.
I ko lākou loiloi ʻana i ka ʻike pinepine ʻana i hoʻokahi pule, ua kiʻekiʻe ka naʻau o ka ʻike PCR no ka lua ihu a me ka saliva, ma kahi o 98%, akā ua hāʻule ka naʻau o ka ʻike antigen i 80%.
Hōʻike nā hopena i ka hoʻohana ʻana i ka hōʻike antigen Covid-19 wikiwiki ma ka liʻiliʻi ʻelua i ka pule no ka hōʻike Covid-19 i hoʻohālikelike ʻia i ka hoʻāʻo PCR a hoʻonui i ka hiki ke ʻike i ka mea maʻi i ka wā mua o ka maʻi.
E hoʻokipa ʻia kēia mau hopena e nā mea hoʻomohala hoʻāʻo antigen wikiwiki, nāna i hōʻike i ka emi ʻana o ke koi no ka hoʻāʻo ʻana o Covid-19 ma muli o ka hoʻokomo ʻana o ka maʻi.
ʻO ke kūʻai aku ʻo BD a me Quidel i nā loaʻa kālā hou loa he haʻahaʻa ma mua o ka manaʻo o ka poʻe loiloi, a ma hope o ka hāʻule ʻana o ke koi no ka hoʻāʻo ʻana iā Covid-19, ua hoʻohaʻahaʻa ʻo Abbott i kāna hiʻohiʻona 2021.
I ka wā maʻi maʻi, ʻaʻole ʻae nā kauka i ka maikaʻi o LFT, ʻoi aku hoʻi no nā papahana hoʻāʻo nui, ʻoiai lākou e hana maikaʻi ʻole i ka ʻike ʻana i nā maʻi asymptomatic.
Ua hōʻike ʻia kahi noiʻi i paʻi ʻia e ka US Centers for Disease Control and Prevention i Ianuali e ʻike ʻia ana ka hoʻāʻo wikiwiki wikiwiki a Abbott BinaxNOW hiki ke hala ma kahi o ʻelua hapakolu o nā maʻi asymptomatic.
I ka manawa like, ua hōʻike ʻia ka hōʻike Innova i hoʻohana ʻia ma UK he 58% wale nō ka naʻau o nā maʻi maʻi Covid-19, aʻo ka hōʻike ʻana o nā pilote i hōʻike ʻia he 40% wale nō ka asymptomatic sensitivity.
Ka manawa hoʻouna: Jul-05-2021